COVID-19 Policy

blood being drawn

HTC Network: A Vital Resource of Patient Care

HTCs are specialized health care centers that bring together a team of doctors, nurses, and other health professionals experienced in treating people with hemophilia. A CDC study of 3,000 people with hemophilia showed that those who used an HTC were 40% less likely to die of a hemophilia-related complication compared to those who did not receive care at a treatment center. Similarly, people who used a treatment center were 40% less likely to be hospitalized for bleeding complications. Join us to learn more about HTCs and the benefits associated with seeking treatment at an HTC.

Date

Apr 20 2022
Expired!

Time

Central Daylight Time
2:00 pm - 3:00 pm

Location

Room 3

Speaker

  • Mark T. Reding, MD
    Mark T. Reding, MD

    Mark T. Reding, MD, is Director of the Center for Bleeding and Clotting Disorders and Professor of Medicine in the Division of Hematology, Oncology and Transplantation at the University of Minnesota in Minneapolis, Minnesota. He earned his medical degree and completed both internal medicine residency and hematology/oncology fellowship training at the University of Minnesota. In addition to clinical and teaching duties, Dr. Reding has laboratory research experience investigating the mechanisms of the immune response to factor VIII and has served as principal investigator of many clinical trials in hemophilia. He is a frequent lecturer both nationally and internationally.

QR Code
Scroll to Top